Uptarvi

Ended Awarded Last action

Contract number
36C26022F0402
Awardee
Awarding agency
Obligated
$200,164

Award facts

Contract value 100% obligated
$200,163.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Titusville, Hopewell Township, NJ 08560, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $18,246
Original award $181,918

About this award

This $200,163.52 delivery order was awarded to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of specialty pharmaceutical products, by the Department of Veterans Affairs (VA) Veterans Health Administration. The order was placed against Actelion's existing five-year, $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows federal agencies to procure pre-negotiated prescription medications. The contract does not have a set-aside designation. The order is for the delivery of various pulmonary arterial hypertension medications, including Opsumit, Uptravi, Tracleer, and Ventavis, to be used by the VA and potentially the Federal Bureau of Prisons to treat affected patients and inmates. Actelion Pharmaceuticals also holds a $60 million Blanket Purchase Agreement with the VA specifically for the procurement of these types of pulmonary hypertension therapies over a five-year period.

Quick answers

Who was awarded contract 36C26022F0402?

36C26022F0402 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 21, 2022.

How much is contract 36C26022F0402 worth?

The government has obligated $200,164 on 36C26022F0402.

Is contract 36C26022F0402 an order under another contract?

Yes. 36C26022F0402 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26022F0402 competed?

The extent of competition for 36C26022F0402 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award